The study results showed that the graphene-based sensor is effective in identifying CEA in serum samples, making it a potentially fast and cost-effective diagnostic tool for monitoring CEA levels, particularly useful in cancers such as colorectal cancer. The gene discussed is CEACAM5; the disease is colorectal cancer.